Gilead to Strengthen Oncology Pipeline with YM BioSciences Purchase

By Heather Cartwright

Pharma Deals Review: Vol 2013 Issue 1 (Table of Contents)

Published: 10 Jan-2013

DOI: 10.3833/pdr.v2013.i1.1869     ISSN: 1756-7874

Section: Mergers & Acquisitions

Fulltext:

Abstract

Gilead Sciences has agreed to acquire YM BioSciences for US$2...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details